Modavar Pharmaceuticals
Manufacturing · District of Columbia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1016 16th St NW Ste 602, Washington, Dis...Phone Number
(202) 355-9785Website
www.modavar.comRevenue
$6.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Modavar Pharmaceuticals
Modavar Pharmaceuticals is a vertically integrated specialty pharmaceutical company that develops, manufactures, and markets prescription pharmaceutical products. As a subsidiary of Cadila Pharmaceuticals, it focuses on delivering affordable, quality formulations through innovative research and cutting-edge manufacturing processes. The company operates FDA-compliant facilities in the U.S. and India, supporting both its product pipeline and contract manufacturing needs for other pharmaceutical companies. Modavar is committed to discovering and marketing pharmaceutical products aimed at preventing, diagnosing, alleviating, and curing diseases.Explore more
Modavar Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Modavar Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Modavar Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Modavar Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Modavar Pharmaceuticals had a recent Job posting/layoffs
Check if Modavar Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Modavar Pharmaceuticals
Funding: Get notified immidiatlly once Modavar Pharmaceuticals has new funding data
Product Launch: Get notified when Modavar Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Modavar Pharmaceuticals recently announced quarterly report
Recommended Actions
Find VP level buyers at Modavar Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Modavar Pharmaceuticals
Compare insights from companies similar to Modavar Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Modavar Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Modavar Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Modavar Pharmaceuticals.
Modavar Pharmaceuticals financials insights
Gather financial insights about Modavar Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Modavar Pharmaceuticals Tech Stack
A closer look at the technologies used by Modavar Pharmaceuticals
See more technologies
Modavar Pharmaceuticals News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Modavar Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Modavar Pharmaceuticals is a vertically integrated specialty pharmaceutical company that develops, manufactures, and markets prescription pharmaceutical products. As a subsidiary of Cadila Pharmaceuticals, it focuses on delivering affordable, quality formulations through innovative research and cutting-edge manufacturing processes. The company oper... Read More
